Research & Development
Accelerating Drug Discovery and Innovation with AI.
Tempus
Tempus is leveraging artificial intelligence and big data analytics to revolutionize precision medicine, offering AI-enabled solutions for drug development, clinical trial optimization, and personalized patient care across multiple diseases.
NVIDIA
NVIDIA provides AI computing platforms and technologies that power advanced medical imaging analysis, genomics research, and drug discovery, accelerating innovation across the healthcare and life sciences industries.
Recursion Pharmaceuticals
Recursion Pharmaceuticals combines AI, machine learning, and automation to create a next-generation biopharmaceutical platform, accelerating drug discovery by leveraging large-scale biological and chemical datasets to decode biology and identify novel treatments.
Atomwise
Atomwise uses AI and deep learning technologies to revolutionize small molecule drug discovery, enabling faster and more efficient identification of potential drug candidates for a wide range of diseases and previously undruggable targets.
Exscientia
Exscientia leverages AI and machine learning to accelerate drug discovery and development, pioneering the use of automated drug design for faster, more efficient creation of high-quality therapeutic candidates.
Insilico Medicine
Insilico Medicine utilizes AI and deep learning to revolutionize drug discovery and development, offering end-to-end solutions from target discovery to clinical trial design and prediction.
BenevolentAI
BenevolentAI combines AI with cutting-edge science to accelerate drug discovery for complex diseases, leveraging its proprietary platform to analyze biomedical data and identify novel drug candidates.
DeepMind (Google Health)
DeepMind, now part of Google Health, applies advanced AI research to healthcare challenges, focusing on medical imaging analysis, disease detection, and clinical decision support to improve patient care outcomes.
Insitro
Insitro integrates machine learning with high-throughput biology to transform drug discovery, leveraging large-scale data to decode biological complexities and accelerate the development of new medicines.
Ginkgo Bioworks
Ginkgo Bioworks uses synthetic biology and AI to program cells for various applications across industries, offering services in cell programming, enzyme optimization, and biosecurity solutions.
Schrödinger
Schrödinger develops computational platforms and software for drug discovery and materials science, using physics-based simulations and machine learning to accelerate the creation of therapeutics and materials.
Relay Therapeutics
Relay Therapeutics focuses on protein motion in drug discovery, using a combination of computational and experimental approaches to develop precision medicines for oncology and genetic diseases.
Valo Health
Valo Health utilizes AI and human-centric data to transform drug discovery and development, integrating computational approaches across the entire drug development lifecycle to accelerate the creation of effective medicines.
Verge Genomics
Verge Genomics leverages AI and patient data to develop treatments for neurodegenerative diseases, using its CONVERGE® platform to analyze multi-omic data and identify therapeutic targets.
XtalPi
XtalPi combines AI, quantum physics, and cloud computing to accelerate drug discovery and development, offering services in crystal structure prediction and AI-powered R&D processes.
Valo Health
Valo Health utilizes AI and human-centric data to transform drug discovery and development, integrating computational approaches across the entire drug development lifecycle to accelerate the creation of effective medicines.
Verge Genomics
Verge Genomics leverages AI and patient data to develop treatments for neurodegenerative diseases, using its CONVERGE® platform to analyze multi-omic data and identify therapeutic targets.
Deep Genomics
Deep Genomics uses AI to revolutionize genetic medicine, focusing on understanding and manipulating RNA biology to develop novel therapies for complex genetic conditions.
Owkin
Owkin uses AI to unlock complex biology and improve precision medicine, focusing on multimodal biomarker discovery, AI diagnostics, and federated learning for secure data analysis in healthcare.
Standigm
Standigm employs AI-driven platforms to streamline drug discovery, offering solutions for novel target identification, lead generation, and drug repurposing to enhance pharmaceutical R&D efficiency.
Iktos
Iktos specializes in AI solutions for medicinal chemistry and new drug design, using generative AI and robotics to accelerate drug discovery and optimize compound design and synthesis.
Unlearn.AI
Unlearn.AI is pioneering the use of AI-powered digital twins in clinical trials to accelerate drug development, reduce costs, and improve the efficiency of bringing new treatments to patients.
Lantern Pharma
Lantern Pharma leverages AI and machine learning to accelerate the drug development process, focusing on precision oncology and the rescue and repurposing of drug candidates for various types of cancer.
Healx
Healx uses AI to accelerate the discovery and development of rare disease treatments, combining machine learning and drug discovery expertise to find new uses for existing drugs and uncover novel compounds.
Cellarity
Cellarity is revolutionizing drug discovery by leveraging AI and machine learning to understand and target cell behavior as a whole, rather than focusing on single molecular targets, to develop more effective therapeutics.
Terray Therapeutics
Terray Therapeutics combines AI with ultra-dense chemical data generation to accelerate small molecule drug discovery, enabling faster and more efficient development of precision therapies.
Genesis Therapeutics
Genesis Therapeutics uses AI-powered drug discovery platforms to accelerate the development of novel small molecule therapeutics, integrating deep learning and molecular simulations to identify promising drug candidates.
Dyno Therapeutics
Dyno Therapeutics employs AI and machine learning to design and optimize novel adeno-associated virus (AAV) vectors, enhancing the efficacy and safety of gene therapies for a wide range of diseases.
Add a company to the AI for Healthcare Hub
Add your company to the directory to showcase your AI solutions and services.
We will review your company and add it to the list.
Stay Updated on AI for Healthcare
Subscribe to our newsletter for the latest updates on artificial intelligence in healthcare.
We respect your privacy. Your information is safe with us.